We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Ticker | Name | Price | Change | Change % | Volume |
---|---|---|---|---|---|
DCPH | Deciphera Pharmaceuticals Inc | 25.02 | 10.37 | 70.78% | 9,429,934 |
INHD | Inno Holdings Inc | 0.9472 | 0.3167 | 50.23% | 11,238,568 |
CSPI | CSP Inc | 18.46 | 4.93 | 36.44% | 13 |
ZVSA | ZyVersa Therapeutics Inc | 6.79 | 1.80 | 36.07% | 1,312,928 |
SRZN | Surrozen Inc | 12.00 | 3.02 | 33.63% | 11 |
TSLL | Direxion Daily TSLA Bull 2X Trust ETF | 8.9898 | 1.84 | 25.73% | 9,490,590 |
TSLT | T Rex 2X Long Tesla Daily Target ETF | 12.28 | 2.50 | 25.56% | 1,991,054 |
TSLR | GraniteShares ETF Trust GraniteShares | 13.50 | 2.73 | 25.35% | 131,892 |
AKAN | Akanda Corporation | 0.1283 | 0.0253 | 24.56% | 21,477,104 |
VCNX | Vaccinex Inc | 7.20 | 1.37 | 23.50% | 86 |
ARQQ | Arqit Quantum Inc | 0.5999 | 0.1122 | 23.01% | 14,738,362 |
Deciphera Pharmaceuticals, Inc. (NASDAQ: DCPH), a biopharmaceutical company focused on discovering, developing, and commercializing important new medicines to improve the lives of people with cancer, today announced that it has entered into a definitive merger agreement with ONO Pharmaceutical Co., Ltd. (ONO), under which ONO will acquire all outstanding shares of Deciphera common stock for $25.60 per share in cash through a tender offer followed by a merger of Deciphera with a wholly-owned subsidiary of ONO (the “Acquisition”), for a total equity value of $2.4 billion. The boards of directors of both companies have unanimously approved the transaction.
MIAMI, April 29, 2024 /PRNewswire/ -- Innovative Eyewear, Inc. ("Innovative Eyewear" or the "Company") (Nasdaq: LUCY; LUCYW), the developer and seller of smart eyewear, today announced that it has entered into a definitive agreement for the issuance and sale of 4,200,822 shares of its common stock at a purchase price per share of $0.244 in a registered direct offering priced at-the-market under Nasdaq rules. Additionally, in a concurrent private placement, Innovative Eyewear has also agreed to issue unregistered warrants to purchase up to 4,200,822 shares of common stock at an exercise price of $0.244 per share. The unregistered warrants will be exercisable beginning on the effective date of stockholder approval of the issuance of the shares ...
UMB Financial Corporation (Nasdaq: UMBF) and Heartland Financial, USA Inc. (Nasdaq: HTLF) announced today that they have entered into a definitive merger agreement under which UMB Financial Corporation (UMB) will acquire Heartland Financial USA, Inc. (HTLF), in an all-stock transaction valued at approximately $2.0 billion.
HONG KONG, April 26, 2024 /PRNewswire/ -- iClick Interactive Asia Group Limited ("iClick" or the "Company") (NASDAQ: ICLK), a leading enterprise and marketing cloud platform in China that empowers worldwide brands with full-stack consumer lifecycle solutions, today announced the termination of the previously announced agreement and plan of merger, dated as of November 24, 2023 (the "Merger Agreement"), by and among the Company, TSH Investment Holding Limited (the "Parent") and TSH Merger Sub Limited (the "Merger Sub").
Ticker | Name | Price | Change | Change % | Market Cap | Volume |
---|---|---|---|---|---|---|
BTC | Bitcoin | 62,129.20 | -855.17 | -1.36% | 1.22T | 2,637,183,342 |
ETH | Ethereum | 3,144.18 | -125.82 | -3.85% | 380.45B | 2,520,344,447 |
USDT | Tether USD | 0.99978 | -0.00022 | -0.02% | 97.82B | 120,071,403 |
BNB | Binance Coin | 585.16 | 10.09 | 1.76% | 92.41B | 259,715,509 |
SOL | Solana | 134.28 | -5.85 | -4.18% | 59.6B | 686,265,534 |
STETH | stETH | 3,142.47 | -118.70 | -3.64% | 31.05B | 5,493,509 |
USDC | USD Coin | 0.9999 | -0.0001 | -0.01% | 28.07B | 428,131,115 |
XRP | Ripple | 0.5037 | -0.00631 | -1.24% | 27.61B | 235,443,303 |
DOGE | Dogecoin | 0.14012 | -0.00868 | -5.83% | 20.17B | 237,299,227 |
TONCOIN | Wrapped TON Coin | 5.23 | -0.356047 | -6.37% | 18.26B | 47,950,873 |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: 1-888-992-3836 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions